Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Use of genomic testing and ketogenic compounds for treatment of reduced cognitive function

Use of genomic testing and ketogenic compounds for treatment of reduced cognitive function

US Patent 10105338 · Granted Oct 23, 2018

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Pharmaceutical compositions having high drug loadings of medium chain triglyceri2023
Use of medium chain triglycerides for the treatment and prevention of Alzheimer'2018
Use of medium chain triglycerides for the treatment and prevention of Alzheimer'2017
Use of genomic testing and ketogenic compounds for treatment of reduced cognitiv2015
Monoglyceride of acetoacetate and derivatives for the treatment of neurological 2015
Use of ketogenic compounds for treatment of age-associated memory impairment2014
Use of medium chain triglycerides for the treatment and prevention of Alzheimer'2013
Use of medium chain triglycerides for the treatment and prevention of alzheimer'2013
Use of ketogenic compounds for treatment of age-associated memory impairment2012
Enzymatic synthesis of acetoacetate esters and derivatives2012
Dynamic photo caller identification2007
Use of medium chain triglycerides for the treatment and prevention of alzheimer'2004